Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Mulligan Richard, Director. Director active across 3 companies, notably BIOGEN INC.. Aggregated, 9 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €547k. Activity tracked since 1 July 2021. The latest transaction was filed on 16 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
9 of 9 declarations
Richard Mulligan is a Board Member at Biogen Inc. and Bausch Health Companies Inc. He is involved in overseeing the operations of these companies and strategic decision-making. With experience in the biopharmaceutical sector, he contributes to the strategic direction of Biogen and Bausch Health, which focus on health innovation.